Hertility 10mg Tablet contains dydrogesterone, a synthetic progestogen used primarily in the management of various gynecological conditions related to progesterone deficiency. Each tablet delivers 10mg of dydrogesterone, which mimics the action of natural progesterone by binding to progesterone receptors, thereby supporting the luteal phase of the menstrual cycle and maintaining pregnancy. Hertility is indicated for the treatment of menstrual disorders such as irregular cycles, secondary amenorrhea, and dysfunctional uterine bleeding. It is also employed in hormone replacement therapy to counteract the effects of estrogen in postmenopausal women and to support early pregnancy in cases of threatened miscarriage or recurrent pregnancy loss due to luteal insufficiency. The medication is generally well-tolerated, with side effects being uncommon but potentially including mild gastrointestinal disturbances, headache, or breast tenderness. Hertility should be used under medical supervision, with dosage and duration tailored to the specific clinical indication and patient response. Contraindications include known hypersensitivity to dydrogesterone, active thrombophlebitis, or undiagnosed vaginal bleeding. Regular monitoring is advised to assess therapeutic efficacy and detect any adverse effects. This medication plays a crucial role in reproductive health by restoring hormonal balance and supporting pregnancy maintenance.